We are live on ! Find out more
KKRC

Kohlberg Kravis Roberts & Co Portfolio holdings

AUM $5.35B
1-Year Est. Return 63.01%
This Fund
S&P 500
This Quarter Est. Return
+16.78%
1 Year Est. Return
+63.01%
3 Year Est. Return
+297.95%
5 Year Est. Return
+219.08%
10 Year Est. Return
+856.54%
AUM
$4.84B
AUM Growth
+$414M
Cap. Flow
-$561M
Cap. Flow %
-11.59%
Top 10 Hldgs %
94.28%
Holding
77
New
3
Increased
3
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
HSIC icon
Henry Schein
HSIC
+$250M
2
CRGY icon
Crescent Energy
CRGY
+$229M
3
QXO.PRB
QXO Inc 5.50% Series B Preferred Stock
QXO.PRB
+$58.4M
4
FOUR.PRA
Shift4 Payments Inc 6.00% Series A Preferred Stock
FOUR.PRA
+$19.2M
5
DEC
Diversified Energy Company
DEC
+$2.81M

Top Sells

Rank Stock Value
1
BTSG icon
BrightSpring Health Services
BTSG
+$331M
2
BBIO icon
BridgeBio Pharma
BBIO
+$218M
3
BV icon
BrightView Holdings
BV
+$174M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 73.79%
2 Industrials 7.08%
3 Energy 5.4%
4 Real Estate 1.81%
5 Communication Services 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTSG icon
1
BrightSpring Health Services
BTSG
$14.3B
$1.82B 37.57%
77,096,338
-15,863,646
-17% -$331M
HSIC icon
2
Henry Schein
HSIC
$9.74B
$1.14B 23.62%
15,652,032
+3,635,318
+30% +$250M
BBIO icon
3
BridgeBio Pharma
BBIO
$16.5B
$573M 11.83%
13,260,971
-6,000,000
-31% -$218M
BV icon
4
BrightView Holdings
BV
$1.31B
$343M 7.08%
21,533,123
-11,600,000
-35% -$174M
CRGY icon
5
Crescent Energy
CRGY
$3.72B
$230M 4.75%
26,758,127
+26,185,773
+4,575% +$229M
KREF
6
KKR Real Estate Finance Trust
KREF
$472M
$87.7M 1.81%
10,000,001
– –
MSGS icon
7
Madison Square Garden
MSGS
$9.54B
$63.7M 1.32%
305,068
– –
BHC icon
8
Bausch Health
BHC
$1.65B
$34.9M 0.72%
5,235,000
– –
DEC
9
Diversified Energy Company
DEC
$914M
$31.4M 0.65%
2,106,785
+209,772
+11% +$2.81M
FSK icon
10
FS KKR Capital
FSK
$2.98B
$20.3M 0.42%
980,587
– –
NCLH icon
11
Norwegian Cruise Line
NCLH
$8.89B
$16.9M 0.35%
831,000
– –
CHRS icon
12
Coherus Oncology
CHRS
$217M
$2.17M 0.04%
3,036,076
– –
QXO.PRB
13
QXO Inc 5.50% Series B Preferred Stock
QXO.PRB
$483M
$620K 0.01%
+1,000,000
New +$58.4M
INSM icon
14
Insmed
INSM
$23.2B
$331K 0.01%
+3,284
New +$251K
FOUR.PRA
15
Shift4 Payments Inc 6.00% Series A Preferred Stock
FOUR.PRA
$608M
$202K ﹤0.01%
+175,000
New +$19.2M
LQD icon
16
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
– –
-72,232
Closed -$7.85M

Similar funds

DPL
Danica Pension Livsforsikrings Copenhagen V $5.33B AUM 18.02% 1-Year Est. Return
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.38B AUM 6.22% 1-Year Est. Return
CBUSF
Construction & Building Unions Superannuation Fund Melbourne, Australia $5.31B AUM 20.68% 1-Year Est. Return
WL
WIT LLC District Of Columbia, District of Columbia $5.3B AUM 20.46% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.28B AUM 23.15% 1-Year Est. Return
FMWA
Forvis Mazars Wealth Advisors Springfield, Missouri $5.27B AUM 18.06% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's Q2 2025 Portfolio in Review

As of Q2 2025, Kohlberg Kravis Roberts & Co held 77 positions worth $4.84B, up 9.3% from $4.43B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Kohlberg Kravis Roberts & Co withdrew a net $561M in Q2 2025, closing 1 position and reducing 3 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $7.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 72% a quarter earlier, followed by Industrials and Energy.

Against the trend, Kohlberg Kravis Roberts & Co opened a new position in QXO Inc 5.50% Series B Preferred Stock worth $620K.

  • Kohlberg Kravis Roberts & Co's largest Q2 2025 buy was QXO Inc 5.50% Series B Preferred Stock: 1,000,000 shares worth $620K.
  • Kohlberg Kravis Roberts & Co added most to Henry Schein in Q2 2025, an estimated $250M increase.
  • Kohlberg Kravis Roberts & Co's biggest Q2 2025 reduction was BrightSpring Health Services, cutting an estimated $331M.
  • Kohlberg Kravis Roberts & Co fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2025, selling an estimated $7.85M.
  • Kohlberg Kravis Roberts & Co's ten largest holdings make up 94% of its $4.84B portfolio in Q2 2025.
  • Kohlberg Kravis Roberts & Co opened 3 new positions and closed 1 in Q2 2025.
  • Kohlberg Kravis Roberts & Co's portfolio value rose 9.3% quarter-over-quarter to $4.84B.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q2 2025, filed 14 Aug 2025.